← All candidates
62 insider filings on record.
62 filings on record.
AMGNAMGEN INC
NasdaqGS · Healthcare · $204.01B
$377.35
+0.02% today
62 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 13 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$204.01B
Float
539.2M
100% public
Short % float
Pro
Price / profit
23.4
Price / future profit
15.5
Price / sales
5.4
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
57 more transactions on Pro →Context
Wall St
$352.77 avg target
-6.5% vs today · 30 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26$5.15 act+$0.38
Q4 '25$5.29 act+$0.56
Q3 '25$5.64 act+$0.63
Q2 '25$6.02 act+$0.74
Coverage
Morgan Stanley Raises Amgen (AMGN) Price Target Following a Strong Start for UpliznaInsider Monkey · 06-14Amgen Faces Dual Turning Point With IMDYLLTRA Gain And Tavneos RiskSimply Wall St. · 06-14Here’s Why Amgen (AMGN) is Among the 7 Best Longevity Stocks to Buy NowInsider Monkey · 06-13Amgen's $500 Million Tavneos Faces FDA Withdrawal FightGuruFocus.com · 06-12
The file stays open
62 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice